Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 2000

View Archived Issues

Pamidronate improves osteoporosis following lung transplant in cystic fibrosis patients

Caprylocaproyl macrogolglycerides increase absorption of intranasal migraine treatment

Triazine derivative inhibits angiogenesis in vivo

MacroMed's OncoGel enters phase I

Cubist acquisition of TerraGen finalized

Drug discovery alliance formed by Synt:em and Morphochem

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Biogen extends trial of interferon beta-1a in multiple sclerosis

Motor complications reduced by pramipexole treatment in early Parkinson's

Early vs. late treatment with antioxidant in hemorrhagic shock

Pharmacological and pharmacokinetic profile of potent Merck HIV protease inhibitor

Sitafloxacin proves useful in serious, difficult-to-treat systemic infections in humans

RSD-1019: a potential new approach to preventing ischemia-induced arrhythmias

Prophylactic vaccine for hospital pathogens presented at ASA 2000

Therion and Aventis expand cancer vaccine alliance

Hepatic metabolism of ciclesonide discussed at Xenobiotics meeting in Japan

New protein from leeches with utility in thromboembolic diseases

Alza's Caelyx approved in E.U. for advanced ovarian cancer

Novel dimeric neuraminidase inhibitors designed at Biota

ADIR presents series with 5-HT reuptake-blocking activity and their use

Recently issued patent covers new melatonin receptor ligands synthesized at ADIR

Wakamoto identifies novel antibiotics for Gram-positive infections

Antifibrotic agents patented by Sumitomo

Banyu claims new series of piperidine chemokine antagonists

RXR-selective retinoids synthesized at Allergan for use in skin and other disorders

Arena reaches milestone in CART collaboration with Taisho

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026